Qingyan Lv

Yangzhou University CN

Publications

463

Citations

H-Index

i10-Index

6.5

2yr Mean Cite

Cite/Paper

Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar

Verify on Google Scholar

Publication & Citation Trends

Publications

0 total

Boosting Fosfomycin Efficacy Against Methicillin-Resistant Staphylococcus aureus Infections by Targeting Pyrimidine Metabolism

Jianya Luo, Qingyan Lv, Mengping He, Zhiqiang Wang, Yuan Liu - Engineering, 2026

Cited by 0 Semantic Scholar

Lon dysfunction-mediated collateral sensitivity drives effective antibiotic combination therapies against tigecycline-resistant pathogens.

Feiyu Yu, Shuyao Zhu, Qingyan Lv, Dan Fang, Haijie Zhang - Cell Reports, 2025

Cited by 2 Semantic Scholar

Non‐Membrane Active Peptide Resensitizes MRSA to β‐Lactam Antibiotics and Inhibits S. aureus Virulence OA

Jingru Shi, Chen Chen, Pan Kong, Feiyu Yu, Qingyan Lv - Advancement of science, 2025

Cited by 10 Semantic Scholar

Research Topics

CRISPR and Genetic Engineering (6) Epigenetics and DNA Methylation (3) Genetic Syndromes and Imprinting (3) Antimicrobial Resistance in Staphylococcus (2) Retinal Development and Disorders (2)

Affiliations

Jilin University

CN 2016 - 2014

Yangzhou University

CN 2026 - 2021

External Profiles

OpenAlex Profile Semantic Scholar Profile Google Scholar

Share Profile

Back to Researchers

Qingyan Lv

Publication & Citation Trends

Publications

Boosting Fosfomycin Efficacy Against Methicillin-Resistant Staphylococcus aureus Infections by Targeting Pyrimidine Metabolism

Lon dysfunction-mediated collateral sensitivity drives effective antibiotic combination therapies against tigecycline-resistant pathogens.

Non‐Membrane Active Peptide Resensitizes MRSA to β‐Lactam Antibiotics and Inhibits S. aureus Virulence OA

Research Topics

Affiliations

External Profiles

Share Profile

Journal Details

Join JournalsHub

Welcome Back